Article No
LS-B10057-0.05
HSPG2 / Perlecan
Perlecan antibody LS-B10057 is an unconjugated rat monoclonal antibody to Perlecan (HSPG2) from human. It is reactive with human, mouse, rat and other species. Validated for ICC, IHC, IP and WB. Tested on 20 human tissues.
Antibodies Primary
Specifications
| NCBI Number | 3339 |
| Application | ICC, IHC, IP, WB |
| Article No | LS-B10057-0.05 |
| Country Availability | SE, FI, DK, NO, FO, GL |
| Clone | A7L6 |
| Clone Type | monoclonal |
| Concentration | 1 mg/ml |
| Conjugation | Unconjugated |
| Description | Perlecan antibody LS-B10057 is an unconjugated rat monoclonal antibody to Perlecan (HSPG2) from human. It is reactive with human, mouse, rat and other species. Validated for ICC, IHC, IP and WB. Tested on 20 human tissues. |
| Recommended Dilution | IHC-Fr (1:50), IP (1:100 - 1:1000) |
| Supplier | LifeSpan Biosciences |
| Entrez Gene ID | 3339 |
| Gene Symbol | HSPG2 |
| Immunogen | High molecular mass material derived from the Engelbreth-Holm-Swarm (EHS) tumor matrix containing laminin, entactin and HSPG |
| Isotype | IgG2a |
| Notes | Perlecan antibody LS-B10057 is an unconjugated rat monoclonal antibody to Perlecan (HSPG2) from human. It is reactive with human, mouse, rat and other species. Validated for ICC, IHC, IP and WB. Tested on 20 human tissues. |
| Alias Names | HSPG2, Endorepellin (domain V region), HSPG, Heparan sulfate proteoglycan 2, Perlecan, Perlecan proteoglycan, SJA, SJS1, PRCAN, SJS |
| Product Type | Antibodies Primary |
| Protocol | ICC, IHC, IHC-Fr (1:50), IP (1:100 - 1:1000), WB |
| Purification | Protein G Purified |
| Shipping Information | RT |
| Size | 0.05 mg |
| Source / Host | rat |
| Species Reactivity | cow/bovine, human, mouse, rat |
| Storage | -20°C, 4°C |
| Substrate / Buffer | PBS, 0.09% Sodium Azide |
| Technical Specifications | Recognizes domain IV of the core protein of the large heparan sulphate proteoglycan or perlecan. The reactivity is independent of the galactosaminoglycan moieties. Therefore, the epitope is not sensitive to heparitinase treatment. |
| Product Page Updated | 2024-04-12T06:35:05.844Z |
